The Phase 1b/2 open label study of CLD-101 will evaluate the safety and feasibility of administering multiple doses of CLD-101 in patients with newly diagnosed high-grade glioma. Eligible patients, ...
Melbourne Storm enforcer Nelson Asofa-Solomona will have his grand final fate determined as he challenges his four-match ...
The Securities and Exchange Board of India (SEBI) is set to convene its board meeting on Monday, the first since Hindenburg ...
Whether you're a casual viewer or a dedicated binge-watcher, these discounts make it easier than ever to access your favorite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback